Clinical trial
Efficacy and Mechanisms of GLN Dipeptide in the SICU
NCT00248638 · Emory University, Other · Completed
Key facts
| NCT number | NCT00248638 |
|---|---|
| Title | Efficacy and Mechanisms of GLN Dipeptide in the SICU |
| Official title | Phase III Study on the Efficacy of Glutamine Dipeptide-Supplemented Parenteral Nutrition in Surgical ICU Patients |
| Acronym | GLND |
| Lead sponsor | Emory University, Other |
| Collaborators | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Critical Illness |
| Intervention type | Drug |
| Interventions | Glutamine dipeptide with 15% Clinisol, 15% Clinisol |
| Enrollment | 150 |
| Start date | Sep 1, 2006 |
| Primary completion | Dec 1, 2012 |
| Completion | Dec 1, 2012 |
| First posted | Nov 4, 2005 |
| Last update posted | Jan 23, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: